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Intake of dietary fibres may reduce the prevalence of physiological risk factors of the metabolic syndrome, such as
high plasma lipid levels and low-grade inflammatory state. Dietary fibres are usually of plant origin however
microbial exopolysaccharides (EPSs) have analogue structures that could potentially exert similar physiological
effects. Pediococcus parvulus 2.6 (Pd 2.6) excretes a ropy EPS and has previously shown probiotic potential. The aim
of this work was to evaluate physiological effects of Pd 2.6 and its EPS in vivo. The live Pd 2.6 (both the ropy and
non-ropy isogenic variant) and its purified EPS were fed to hypercholesterolemic LDL-receptor deficient mice for
6 weeks to investigate their effects on cholesterol levels and the inflammatory tone of the animals. Both variants of
Pd 2.6 survived passage through the mouse gut fulfilling an important criterion of probiotics. The ability to produce
EPS was conferring an advantage to survival (faecal recovery of 3.7 (1.9-8.7) vs. 0.21 (0.14-0.34) *108 CFU, P < 0.001,
median and 25th and 75th percentiles). The ropy Pd 2.6 decreased the levels of soluble vascular cell adhesion
molecule-1 compared to the EPS alone (591 ± 14 vs. 646 ± 13 ng/ml, P < 0.05). An increase in liver weight in mice
fed the purified EPS was observed, but with no change in liver lipids. No changes in blood lipids were detected in
any group. Further the EPS induced growth of the caecal tissue and increased the amount of caecal content
showing bulking properties like that of a dietary fibre.
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Central obesity, hypertension, dyslipidaemia and insulin
resistance are all independent risk factors for cardiovas-
cular disease and type 2 diabetes. Co-occurrence of these
metabolic abnormalities is stated as the metabolic
syndrome (Eckel et al. 2010) which is associated with
elevated levels of pro-inflammatory cytokines and in-
flammatory markers indicating a chronic inflammatory
state (Galisteo et al. 2008). Life style intervention, in-
cluding dietary changes, is suggested as a primary ther-
apy for the metabolic syndrome (Grundy et al. 2005)
and dietary fibres, including β-glucans, have been identi-
fied as important substances in the management of the
metabolic abnormalities within the syndrome (Delzenne* Correspondence: cecilia.lindstrom@biotek.lu.se
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in any medium, provided the original work is pand Cani 2005; Galisteo et al. 2008). Recently the com-
position of the intestinal microflora has been acknowl-
edged as an important factor in regulating the body
weight (Bäckhed et al. 2004; Cani and Delzenne 2009;
Ley et al. 2006) and could be used in fighting central
adiposity. The microbiota may be altered by prebiotics
that selectively stimulate the growth and/or activity of
intestinal bacteria that can be associated with improve-
ment of the host health. Such prebiotics should resist
gastric acid and hydrolysis by host enzymes to be able to
reach the gut and there be selectively fermented by the
microbiota (Gibson et al. 2004). Another approach for
modulation of physiological parameters is through the
application of probiotics; living microorganisms which
confer a health benefit to the host when administered in
sufficient amounts (FAO/WHO 2002). The genus Bifido-
bacterium and species belonging to the group of lactic
acid bacteria (LAB) like Lactobacillus are the most com-
monly used probiotics (Saad et al. 2013).is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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such as dairy products, cereals, vegetables and various
beverages. These strains are acid tolerant and may be
adaptable to intestinal conditions and survive the pas-
sage through the gastrointestinal tract. This opens up
the possibility to use potential probiotic strains from
other niches than those of animal origin that are com-
monly used. The production of exopolysaccharides
(EPSs) is a trait common to several LAB (Duboc and
Mollet 2001) and there are numerous reasons for choos-
ing EPS-producing LAB to test their potential probiotic
properties. It has previously been shown that LAB and
prebiotics show a synergistic effect on cholesterol me-
tabolism (Mandal et al. 2009) and that LAB alone may
provoke a cholesterol lowering effect in vivo (Bukowska
et al. 1998; Park et al. 2007; Wang et al. 2009; Xie et al.
2011) where the presence of EPSs might increase the ef-
fect (Tok and Aslim 2010). The presence of EPSs from
various LAB has been shown to reduce biofilm forma-
tion of pathogens in vitro (Kim et al. 2009), modulate
adhesion to intestinal epithelial cells in vitro depending
on type and dose of EPS (Ruas-Madiedo et al. 2006),
reduce colitis in mice (Şengül et al. 2011) and selectively
enhance the growth of bifidobacteria (Hongpattarakere
et al. 2012; Korakli et al. 2002; Salazar et al. 2008; Salazar
et al. 2009) showing a prebiotic potential. Further the EPS
kefiran suppress increases in blood pressure, reduce serum
cholesterol levels, lower blood glucose levels in rats (Maeda
et al. 2004) and induce an immunological response in mice
gut mucosa (Vinderola et al. 2006) indicating that EPS may
be used to control the abnormalities occurring in the meta-
bolic syndrome.
Since both LAB and their EPSs may have health bene-
ficial effects it is of interest to compare physiological
parameters after ingestion of pure EPS and the live bac-
teria. The LAB Pediococcus parvulus derived from alco-
holic beverages has a great capacity to withstand
environmental stress (Dols-Lafargue et al. 2008) and it
has been shown to resist gastrointestinal stress in vitro
(Fernández de Palencia et al. 2009; Immerstrand et al.
2010). P. parvulus 2.6 (Pd 2.6) has been isolated as a
contaminant in Basque Country cider (Fernandez et al.
1995) and it produces a 2-substituted (1,3)-β-D-glucan
(β-glucan) that is excreted into the surroundings as a
ropy EPS causing unwanted alterations to the beverage
known as ropiness; long slimy filaments of EPS may
be picked up from the liquid (Duenas-Chasco et al.
1997). (Mårtensson et al. 2005) showed that a ropy oat
based product fermented with Pd 2.6 induced a hypo-
cholesterolemic effect in humans whereas the fermented
non-ropy oat product did not (Martensson et al. 2005).
Further, the ropy oat based product fed to rats in a
freeze dried, sterilized form did not reduce plasma chol-
esterol; partly explained by the fact that the activecomponent was given in a dry form compared to a fully
solubilized form (Martensson et al. 2002). It should also
be noted that the feed had been sterilized, hence no liv-
ing Pd 2.6 was present in the product. This raises the
question whether the cholesterol-lowering effect was
attributed to the live Pd 2.6, the presence of EPS in the
product or a synergistic effect with the oats. In addition
the solubilisation of the material needs to be taken into
account. The present investigation was set up to try to
elucidate whether the hypocholesterolemic effect could
be attributed to either the EPS or the live Pd 2.6. Mice
were fed a diet containing purified EPS from Pd 2.6 (2%)
and live Pd 2.6 both as the ropy and the isogenic non-
ropy variant. By including the non-ropy variant synergis-
tic effects between the bacteria and the EPS could be
ruled out. The different additions were incorporated into
the diets in a wet form. The survival of Pd 2.6 through
the gastrointestinal passage and possible bioactive prop-
erties elicited by the Pd 2.6 and/or its EPS were eva-
luated. Specifically it was investigated if Pd 2.6 and/
or its EPS have cholesterol-lowering activities or anti-
inflammatory effects of low-grade systemic inflammation –
both of importance in the metabolic syndrome.
Materials and methods
Production of EPS from ropy Pediococcus parvulus 2.6
Growth of Pd 2.6
Pd 2.6 was obtained from the Universidad de Pais Vasco
culture collection, San Sebastian, Spain and stored at -80°C
in MRS broth (Merck, Darmstadt, Germany) containing
20% glycerol (v/v). After revival the culture was routinely
kept at 4°C in MRS broth containing 5% ethanol (Prolabo,
VWR, Fontenay-sous-Bois, France), and subcultured every
two weeks. Active liquid cultures were stepwise inoculated
(2-5%) in MRS broth containing 0.2% sodium thioglycolate
(Sigma, Sigma Aldrich Chemie, Steinheim, Germany) as
oxygen scavenger. Finally 200 litres of media (Bioreactor
BR600, Belach Bioteknik AB, Stockholm, Sweden) was
inoculated and kept under soft agitation (20 rpm) to be able
to maintain a constant temperature of 30°C. The head-
space was flushed with nitrogen to keep an anaerobic
atmosphere. The cultivation was not pH-controlled. The
fermentation was terminated after 5.5 days and the broth
was stored at 4°C until processed.
Isolation and purification of EPS
Trichloroacetic acid 40% (w/v) (Carl Roth, Germany)
was added as 1/3 of the volume to the cultivation broth.
The insoluble material was removed by centrifugation
(7800 g, Sorvall RC 3C Plus, Thermo Scientific, 30 min
room temperature). Three volumes of cold 95% ethanol
(Solveco, Rosersberg, Sweden) were added to the super-
natant and the precipitate was allowed to sediment at
10°C for at least 24 h. The precipitate was collected by
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sequentially dissolved in reversed osmosis water (Barnstead
Nanopure, Thermo Scientific) and freeze dried (Ninolab,
Upplands Väsby, Sweden). The freeze drier was pro-
grammed (Eurotherm, Malmö, Sweden) to start at -25°C
for 3 h and then increase the temperature 1°C/min to -5°C
and stay there for 12 h. The temperature was then
increased to 5°C by 1°C/min and held for 12 h. Finally the
temperature was increased 1°C/min to 25°C and held there
for 1-2 days. The dry EPS was stored at room temperature.
Protein content of EPS
The protein content of the dry EPS was measured with
the Pierce BCA Protein Assay Kit (Thermo Scientific,
Rockford, IL, USA) according to the manual. The EPS
was diluted in distilled water and analysed in duplicates.
Molar mass determination of EPS using asymmetrical flow
field-flow fractionation
Sample preparation
Samples for asymmetrical flow field-flow fractionation
(AF4) were prepared by dissolving the EPS (1 mg/ml) in
sodium nitrate buffer (10 mM) at room temperature by
gentle stirring (200 rpm). The carrier liquid used in AF4
was an aqueous solution of 10 mM NaNO3 (AppliChem,
Darmstadt, Germany) and 0.02% NaN3 (Kebo Lab,
Spånga, Sweden).
Instrumentation
The system used was an Eclipse 3+ AF4 instrument con-
nected to a Dawn Heleos II multiangle light scattering
(MALS) detector and an Optilab T-rEX differential re-
fractive index (RI) detector both operating at a wave-
length of 658 nm (Wyatt Technology, Santa Barbara,
CA, USA). The carrier flow was delivered by a pump
with an in-line degasser; an auto-sampler handled the
sample injection (1100 series, Agilent Technologies, Palo
Alto, CA, USA). The AF4 Wyatt short channel was
made up of a Wyatt wide spacer with a thickness of
250 μm, the tip to tip channel length 174 mm. A 20 nm
pore size aluminium oxide filter in a Teflon filter holder
was placed between the pump and the channel in order
to ensure that a particle free solvent entered the channel.
The ultrafiltration membrane on the accumulation wall
was regenerated cellulose with a cut-off of 10 kDa
(Microdyn Nadir Filtration, Wuppertal, Germany).
The sample was injected onto the channel at a flow
rate of 0.2 ml/min for 1.0 min and the focusing flow rate
was 1.0 ml/min. The injected amount was 400 μg. The
cross-flow during elution started at 1.0 ml/min and was
decreased exponentially with a half life of 4.0 min. The
channel outlet flow was kept constant at 1.0 ml/min
during the whole separation.The light scattering data were processed using Astra
software (Wyatt Technology). The molar mass was
obtained by Berry’s method (Andersson et al. 2003; Berry
1966), fitting a straight line to the data obtained at scat-
tering angles 38-99°. The refractive index increment value
(dn/dc) was set to 0.146 ml/g based on the fact that most
polysaccharides in aqueous solution have values in the
range of 0.13-0.15 (Branderup and Immergut 1989). This
may lead to an uncertainty of about 10% in the molar
mass value obtained (Lambo-Fodje et al. 2007).
Plasmid curing
Polysaccharide synthesis in Pd 2.6 is controlled by a 567-
amino acid, 65 kDa glucosyltransferase (GTF) that regu-
lates polymerization of glucosyl residues from UDP
glucose (Werning et al. 2006). The gtf gene is found on a
35-kb plasmid, pPP2 (GenBank accession no. AY999683).
When the plasmid is cured the ropy trait is permanently
lost and the strain becomes unable to synthesize EPS
(Fernandez et al. 1995). In the present study the isogenic,
non-ropy variant of Pd 2.6 was obtained by subculturing
the ropy strain in MRS broth at 30°C leading to curing of
its pPP2 plasmid and sequential permanent loss of its EPS
producing trait. To confirm the new variant as Pd 2.6 16S
rRNA gene sequencing was performed. Genomic DNA
was extracted as described (Sambrook and W. Russell
2001) and the 16S rRNA coding gene was amplified by
PCR using the universal primers 8 F (50-AGA GTT TGA
TCC TGG CTC AG-30) and 1492R (50-GGT TAC CTT
GTT AGG ACTT-30) (Eurofins, Germany) and Phusion
High-Fidelity DNA Polymerase (Finnzymes, Vantaa,
Finland). The PCR product was separated by agarose
(0.8% w/v) gel electrophoresis, excised and purified with
QIAquick PCR Purification Kit (Qiagen, Germany)
according to the instructions provided by the manufac-
turer. Sequencing was performed by GATC Biotech AB
(Konstanz, Germany) and the sequence was analysed with
the Basic Local Alignment Search Tool (BLAST, www.
ncbi.nml.nih.gov). Identification was performed on the
basis of 16S rRNA sequence similarity.
Diets
The composition and energy content of the Western diets
are presented in Tables 1 and 2 respectively. All diets were
having microcrystalline cellulose (Avicel PH 101, FMC
Biopolymer) as the fibre source. Fresh diets were prepared
daily by adding MRS broth (Merck) to the pre-mixture
(Research Diets Inc., New Brunswick, NJ, USA) at a con-
centration of 20% (v/w). The different groups were divided
based on the additions made to the MRS broth. Group A
served as control with pure MRS broth added. Purified
EPS from Pd 2.6 was dissolved in MRS broth and added
to the diet of Group B at a final concentration of 2% EPS
based on dry matter. The amount of cellulose was
Table 1 Formulation of the experimental diets (g/kg diet)
Ingredient Diets EPS diet
Casein, 80 mesha 200 200
DL- methionine 3 3
Waxy corn starch 286 286




Butter, anhydrousb 200 200
Corn oil 10 10
Mineral mix S10026 10 10
Dicalcium phosphate 13 13
Calcium carbonate 5.5 5.5
Potassium citrate 1 H2O 16.5 16.5
Vitamin mix V10001 10 10
Choline bitartrate 2 2
EPS, exopolysaccharide.
aCasein is 88% protein.
bAnhydrous butter contains 230 mg cholesterol per 100 g. The amount of
cholesterol in all diets were 0.46 g/kg diet.
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the control (4%). For group C and D the MRS broth was
inoculated with 0.6% Pd 2.6 of the ropy (Pd 2.6 R) and
non-ropy (Pd 2.6 NR) variant respectively. The cultiva-
tions were incubated at 30°C for 48 h before addition to
the diet. Consequently the diets of group C and D con-
tained live bacteria upon administration. The amount of
live bacteria administered was determined by plating serial
dilutions of the MRS broth prepared in physiological sa-
line on MRS agar (Merck) containing 5% ethanol (Sol-
veco). The plates were incubated at 30°C for 48 h in
anaerobic jars (Anaerocult, Merck).
Animals
LDL-receptor deficient mice (LDLr-/-) have successfully
been used to study effects on blood lipids of dietary
components (Andersson et al. 2010b; Dupasquier et al.
2007). The reduction of plasma cholesterol is relatively
larger in LDLr-/- compared to wild type mice (Andersson
et al. 2010a; Andersson et al. 2010b) hence to be able toTable 2 Energy and macronutrient content of the
experimental diets
Diets EPS diet
Protein (% energy) 16 16
Carbohydrate (% energy) 48 48
Fat (% energy) 36 36
Energy (kJ/g diet) 16 16
EPS, exopolysaccharide.detect small changes in plasma cholesterol levels the
LDLr-/- was chosen for the present experiment. Female,
homozygous LDL-receptor deficient mice (WEIBL. B6.
129S7 Ldlrtm1Her/J, Charles River, Sulzfeld, Germany)
were randomly divided into four groups of ten animals
upon arrival and acclimated for two weeks while being
fed normal chow (R34 rodent chow, Lactamin, Vadstena,
Sweden). The animals were housed in groups of 10 in
plastic cages with housing material (22°C, relative air hu-
midity 60%, 12 h light/dark cycle) having unlimited sup-
ply to feed and water. After acclimatization, at the age of
9-10 weeks (body weight 18.1 ± 1 g), the mice were fed a
high fat, Western type experimental diet for six weeks.
Feed intake and body weight were followed throughout
the study.
At the end of the study the animals were anesthetized
by isofloran and killed by cervical dislocation. Caecum
content and livers were collected and snap frozen in li-
quid nitrogen and stored at -80°C. The emptied caecum
tissue was weighed. Blood was collected from the heart
and centrifuged (5000 g, Eppendorf ) for 10 min at 4°C.
The serum was stored at -80°C. The experiment
followed national guidelines for the care and use of
animals and were approved by Malmö/Lund ethical
committee for laboratory animals (ethical permission
number: M72-11).
Survival of Pd 2.6 through the gastro intestinal tract
Fresh faeces was collected from the mice and stored at
-80°C until suspended in physiological saline and cul-
tured on MRS agar plates containing 5% ethanol (Sol-
veco). The plates were incubated aerobically at 30°C for
four days.
Plasma cholesterol, triglycerides and serum alanine
aminotransferase
Blood was collected from the saphenous vein into EDTA
coated microvette tubes after 4 h of morning fasting and
centrifuged (5000 g, Eppendorf ) for 10 min at 4°C. The
plasma was stored at -80°C. Plasma cholesterol and tri-
glyceride concentrations were measured in duplicates
using the Infinity Cholesterol/Triglyceride Liquid Stable
Reagent (Thermo Scientific, Melbourne, Australia) accord-
ing to the standard protocol. Alanine aminotransferase
(ALT) was analysed in serum by the accredited laboratory
Clinical Chemistry, Lund University Hospital, Lund,
Sweden.
Total bile acids in faeces
At week 6 each group of animals were randomly divided
into three subgroups of 3-4 mice and placed on grills for
24 h. Faeces were collected, lyophilized and mortared.
Bile acids were extracted from faeces in 75% ethanol for
two hours at 50°C while shaking (Yu et al. 2000). Solids
Figure 1 Differential molar mass distribution of the EPS
produced by Pd 2.6 obtained from AF4-MALS-RI.
Table 3 Pd 2.6 recovered in faeces
Pd 2.6 in faeces
(108 CFU)
Median 25-75% n
Pd 2.6 R 3.7a 1.9-8.7 12
Pd 2.6 NR 0.21b 0.14-0.34 10
Normality test failed so a Mann-Whitney Rank Sum Test was performed. Data
are expressed as median and 25th and 75th percentiles. Groups with unlike
superscript letters were significantly different (P < 0.001).
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The supernatant was analysed in duplicates by the Col-
orimetric Total Bile Acids Assay Kit (Diazyme Labora-
tories, CA, USA) modified to suit a 96-well plate assay.
Lipid extraction from liver
Frozen livers were mortared under liquid nitrogen and
freeze dried. Liver lipids were extracted in n-hexane:iso-
propanol (3:2, Merck) with 0.005% butylhydroxytoluene
(Fluka) for 1 h at room temperature while shaking. The
supernatant was removed after centrifugation and the
pellet was washed three times in the solvent. The super-
natants were collected and evaporated under nitrogen
gas at room temperature. The lipids were redissolved in
isopropanol containing 1% Triton X-100 (Sigma Aldrich)
at 37°C while shaking for 15 min. Total cholesterol and
triglycerides were analysed in duplicates using Infinity
Cholesterol/Triglyceride Liquid Stable Reagent (Thermo
Scientific, Melbourne, Australia) according to the stand-
ard protocol modified to suit a 96-well plate.
Markers of the inflammatory tone
Serum was thawed on ice and Serum amyloid A (SAA)
and soluble vascular cell adhesion molecule-1 (sVCAM-
1) were measured by ELISA kits (Tridelta Development,
Kildare, Ireland and R&D systems, Abingdon, UK re-
spectively) according to instructions provided by the
manufacturers. Samples were analysed in duplicates.
Statistics
Data analysis was performed using Sigma Plot 11.0
(Systat Software Inc.) using one-way ANOVA for mul-
tiple comparisons followed by Tukey’s test to determine
significance of difference between groups. Results are
presented as mean values and their standard error of
mean. Data failing the normality test were analysed by
the Kruskal-Wallis one-way analysis followed by Dunn’s
method for pair-wise multiple comparisons between
groups, and expressed as median values with the 25th
and 75th percentiles. Values with P < 0.05 were consid-
ered statistically significant.
Results
Production and characterization of EPS
About 30 g of EPS was obtained from 100 litres of broth
giving a yield of 300 mg/L. The EPS contained 10% pro-
tein. The main population of the EPS was showing a
molecular weight of about 106 Da (Figure 1).
Survival of Pd 2.6 through the gastrointestinal tract
The groups fed live bacteria ingested Pd 2.6 (R and NR)
at levels of 108 CFU/g of feed (3.4*109 CFU/mouse and
day). In the present study faeces were inoculated on
MRS containing ethanol (5%) to selectively grow Pd 2.6.Both the ropy and non-ropy variants were present as the
only bacteria on the plates as confirmed by microscopy.
The recovery of Pd 2.6 R was 17-fold higher than Pd 2.6
NR (Table 3).
Physiological responses
There was no difference in feed intake (3.4 ± 0.04 g per
mouse and day) and final body weight (23.6 ± 0.4 g) be-
tween groups as expected on an isocaloric diet. Caecal
tissue weight and caecal content were significantly
increased in the EPS group compared to the control
(Table 4) showing a bulking effect resulting in enlarge-
ment of the organ. The faecal output and amount of
total bile acids in faeces did not differ between groups
(Table 4), and neither did plasma cholesterol and trigly-
cerides (Table 5).
Serum concentrations of inflammatory markers SAA
and sVCAM-1 are presented in Table 5. The sVCAM-1
level was significantly lower for the group Pd 2.6 R com-
pared to Pd 2.6 EPS.
The liver weight was significantly higher in the EPS
group compared to the control. Sometimes this is a sign
of fatty liver, but when the liver lipid contents were ana-
lysed no differences were found between groups
(Table 6). Further the presence of elevated liver enzymes
Table 4 Caecal tissue weight, caecal content, faecal output and concentration of bile acids in faeces
Caecal tissue weight Caecal content Faecal output Bile acids in faeces*
(g) (g) (g/mouse*24 h) (μmol/mouse*24 h)
Mean SEM n Mean SEM n Mean SEM n Median 25-75% n
Control 0.047a 0.002 10 0.14a 0.01 10 0.124 0.026 3 1.5 1.2-1.8 3
Pd 2.6 EPS 0.057b 0.002 10 0.18b 0.01 10 0.128 0.029 3 1.3 1.0-1.9 3
Pd 2.6 R 0.048a 0.002 10 0.13a 0.01 10 0.123 0.017 3 1.9 1.4-2.0 3
Pd 2.6 NR 0.051ab 0.002 10 0.16ab 0.01 10 0.113 0.028 3 1.8 0.8-2.3 3
n, number of observations.
Statistics were calculated using one-way ANOVA for multiple comparisons. Tukey’s test was used for pairwise comparisons of means.
* These data failed the normality test so a Kruskal-Wallis one-way analysis of variance on the ranks was run followed by Dunn’s method for pairwise multiple
comparisons. Groups with unlike superscript letters were significantly different (P < 0.05).
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there were no significant differences between groups for
serum ALT levels and there was no correlation between
liver weight and serum ALT concentration (result not
shown).
Discussion
Dietary fibres, specifically β-glucans, have been recog-
nized as important substances with potential to regulate
certain physiological parameters like the glycaemic re-
sponse, hypertension and dyslipidaemia. There are sev-
eral reports on the beneficial effects of cereal (Tiwari
and Cummins 2011) and fungal (Kim et al. 2005; Mattila
et al. 2000) β-glucans. Information about the effect of β-
glucans from LAB is however scarce. Studies of specific
physiological effects for structurally different β-glucans
in animal and clinical trials are of great interest and it is
of importance to characterize the β-glucans used (Chen
and Raymond 2008). Therefore in the present study a β-
glucan of known structure, the 2-substituted (1,3)-β-D-
glucan produced by Pd 2.6 (Duenas-Chasco et al. 1997),
was investigated concerning its effects on plasma lipids
and inflammatory markers. The EPS was containing 10%
protein of unknown identity however the protein con-
tent was not taken into account when the EPS was
added to the diet. The molar mass distribution of the
EPS was determined using AF4-MALS-RI (Figure 1) and
the main population (highest peak) was showing a molarTable 5 Concentrations of plasma cholesterol, triglycerides an
Plasma cholesterol* Plasma triglycerides*
(mmol/L) (mmol/L)
Median 25-75% n Median 25-75%
Control 23.9 20-25 10 4.6 4.4-5.8
Pd 2.6 EPS 24.8 22-26 10 5.5 4.6-6.7
Pd 2.6 R 22.0 21-24 10 4.3 3.5-5.8
Pd 2.6 NR 20.2 16-25 10 4.3 3.4-5.3
SAA, serum amyloid A; sVCAM-1, soluble vascular cell adhesion molecule-1.
Statistics were calculated using one-way ANOVA for multiple comparisons. Tukey’s t
* These data failed the normality test so a Kruskal-Wallis one-way analysis of varian
comparisons. Groups with unlike superscript letters were significantly different (P <mass distribution of about 106 Da in accordance with
earlier reports (Lambo-Fodje et al. 2007). The popula-
tion showing a higher molar mass (Figure 1) was of un-
known origin however it could be an aggregated form of
the EPS due to the high molar mass species present (M
> 108 g/mol). Figure 1 also shows the strength of AF4
being able to separate species of a very wide size range.
The EPS was added to the experimental diet solubilised
in its native form. The yield of the EPS is not feasible for
commercial production of pure EPS therefore in situ
production would probably be a better option. It has
been shown that the presence of a food matrix like or-
ange juice may increase the survival of Pd 2.6 when
exposed to gastric stresses. The food is not negatively
affected by the presence of Pd 2.6 which means that it
can be used as a mean to administer the EPS and bac-
teria in vivo easily (Elizaquivel et al. 2011).
To our knowledge no reports exist on the survival of
Pd 2.6 after passage through the gastrointestinal tract
in vivo. In the present study both Pd 2.6 R and NR was
isolated from faeces showing the ability of this LAB to
survive the passage through the mouse gastrointestinal
tract. The survival in the gut is a prerequisite for pro-
biotic bacteria (FAO/WHO 2002) and the survivability
of Pd 2.6 previously investigated in vitro (Fernández de
Palencia et al. 2009; Immerstrand et al. 2010) was con-
firmed. The previous in vitro trial showed that the pres-
ence of EPS does not confer an advantage of survival ford serum SAA and sVCAM-1
SAA* sVCAM-1
(ug/ml) (ng/ml)
n Median 25-75% n Mean SEM n
10 25.8 22.2-27.6 9 610ab 12 10
10 24.9 24.0-31.1 10 646a 13 10
10 24.7 20.0-29.5 9 591b 14 10
10 21.5 20.2-26.3 10 629ab 10 10
est was used for pairwise comparisons of means.
ce on the ranks was run followed by Dunn’s method for pairwise multiple
0.05).
Table 6 Liver weight and concentration of total cholesterol and triglycerides in liver
Liver weight per body weight* Total cholesterol in liver Triglycerides in liver
(mg/g) (mg/g) (mg/g)
Median 25-75% n Mean SEM n Mean SEM n
Control 45.1a 44-47 10 13.5 0.45 10 60.3 5.0 10
Pd 2.6 EPS 58.1b 53-64 10 12.8 0.55 10 64.4 4.0 10
Pd 2.6 R 48.4a 44-51 9 11.9 0.30 10 50.3 4.5 10
Pd 2.6 NR 50.4ab 45-53 8 12.8 0.69 10 65.0 6.6 8
n, number of observations.
Statistics were calculated using one-way ANOVA for multiple comparisons. Tukey’s test was used for pairwise comparisons of means.
* These data failed the normality test so a Kruskal-Wallis one-way analysis of variance on the ranks was run followed by Dunn’s method for pairwise
multiple comparisons.
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2009) however when the EPS is heterologously expressed
in Lactobacillus paracasei it gives an advantage of sur-
vival to both technological and gastrointestinal stresses
compared to the wild type strain (Stack et al. 2010). The
present study showed that the ropy variant was found in
significantly larger numbers in faeces from mice com-
pared to the non-ropy strain (Table 3). Since EPS pro-
duction is the obvious thing that differs between the two
isogenic variants it is suggested that the EPS increases
the survival and ability to enumerate in the mouse gut
in vivo. There are no defined dosages for probiotics
today (Saad et al. 2013) however a daily dose of
3.4*109 CFU for Pd 2.6 was sufficient for reaching and
surviving in the intestinal tract of mice. Adhesion prop-
erties are often used as a selective factor when searching
for new probiotics (Saad et al. 2013) and adhesion of Pd
2.6 to Caco-2 cells has previously been investigated
in vitro. The results revealed that the ropy variant shows
a higher level of adherence compared to the non-ropy
variant (Fernández de Palencia et al. 2009). The ability of
adhesion of Pd 2.6 R caused by the presence of EPS may
explain the fact that it was found in higher numbers
than Pd 2.6 NR in the gut of the mice.
The purified EPS induced growth of the caecum organ
due to a bulking effect showing that it was acting as a
dietary fibre. This effect of EPSs has been shown previously
(Lindström et al. 2012). The bulking effect was not shown
by Pd 2.6 R probably due to the concentration of EPS being
too low to impart a significant effect. The bulking effect of
polysaccharides is often caused by increased bacterial acti-
vity or increased water holding capacity. The faecal out-
put and amount of water contained within the faeces
(11-12.5%) was not different between groups indicating that
bacterial activity was causing the bulking effect. The EPS
from Pd 2.6 was probably acting as a substrate for various
bacteria and further studies characterizing the microbiota
would be interesting to perform trying to elucidate what
kind of bacteria that were stimulated by the EPS. If these
bacteria are belonging to the genera Bifidobacterium and/
or Lactobacillus the EPS might be considered prebiotic.The hypocholesterolemic effect seen in humans after
ingestion of ropy fermented oats (Martensson et al.
2005) could not be reproduced in the present study
where mice were fed single constituents from the
complex fermented product. The pure EPS and live Pd
2.6 were hypothesised to be the active components.
However these additions were not giving a cholesterol
lowering effect in mice when administered as the sole
ingredient. In the study of (Mårtensson et al. 2005) non-
ropy fermented oats failed to show a cholesterol lower-
ing effect. Thus it seems like the hypocholesterolemic
effect was achieved as a protective and/or synergistic
effect between oats and the EPS and/or Pd 2.6. Oats and
barley contain (1,3)(1,4)-β-D-glucans (Webster and
Wood 2011) whereas fungal β-glucans are (1,3) linked
with branches at the (1,6) position (Chen and Raymond
2008). Thus the β-glucan produced by Pd 2.6 has a dif-
ferent chemical structure compared to those β-glucans
that have previously been reported to exert hypocholes-
terolemic effects. Hence the lack of effect by the EPS
may be explained by the absence of structural features
that are needed for plasma lipid regulation.
(Notararigo et al. 2011) tested the influence of pure
EPS from Pediococcus strains on gut mucosa in vitro by
analysing the cytokine production by macrophages. They
showed that the purified EPS increases the interleukin
10/tumour necrosis factor α ratio indicating an anti-
inflammatory effect (Notararigo et al. 2011). In the
present study the acute phase proteins SAA and the sol-
uble variant of the adhesive molecule VCAM-1 were
measured to investigate whether the EPS or live Pd 2.6
induced an anti-inflammatory response in mice. SAA
did not differ between groups but sVCAM-1 was signifi-
cantly lower for the Pd 2.6 R group compared to the
pure EPS. There was a significant difference (P = 0.045, stu-
dent’s t-test) between Pd 2.6 R and Pd 2.6 NR where intake
of the ropy variant resulted in lower levels of sVCAM-1. In
agreement with this (Fernàndez de Palencia et al. 2009)
showed that the presence of EPS counteracts the pro-
inflammatory response observed with Pd 2.6. In their study
the amount of EPS was produced by the bacteria itself.
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http://www.amb-express.com/content/2/1/66(Notararigo et al. 2011) did not report the concentration of
EPS used in their study however if small amounts were
used the result from the two above mentioned studies may
indicate that a level of EPS that would be produced by the
bacterium is giving anti-inflammatory effects. However an
increased level of EPS (2%) used in the present study was
increasing the inflammatory tone upon ingestion.
In conclusion it seems like a better choice to incorpor-
ate the EPS-producing bacteria rather than the pure EPS
in foods both from a technological and physiological
standpoint. The yield of the EPS is low and apparently it
does not give the favourable immunological response
observed with the bacterium. Pd 2.6 was able to survive
the passage through the intestinal tract of mice, where
the ability to produce EPS conferred an advantage to
survival in the gut, strengthening the assumption that
probiotic bacteria may be found outside the commonly
used genera of Bifidobacterium and Lactobacillus. How-
ever the physiological responses investigated here for Pd
2.6 (R and NR) were not different compared to the con-
trol group without bacteria and further studies are
needed to determine specific positive physiological
effects correlated to the presence of Pd 2.6 before it can
be considered probiotic.
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